Status:
UNKNOWN
Clinical Risk Assessment of Cognitive Function in Systemic Autoimmune Diseases
Lead Sponsor:
University of Pecs
Conditions:
Systemic Sclerosis
Systemic Lupus Erythematosus
Eligibility:
All Genders
18+ years
Brief Summary
Objectives: Systemic autoimmune diseases are chronic diseases characterized by chronic inflammation, vasculopathy, and autoimmune phenomena. Several organ involvements are typical, including the centr...
Eligibility Criteria
Inclusion
- Systemic autoimmune diseases
- Healthy individuals - as controls
Exclusion
- Diseases of the central nervous system
- Presence of pregnancy
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 30 2023
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06029335
Start Date
September 1 2020
End Date
August 30 2023
Last Update
September 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pécs, Department of Rheumatology and Immunology
Pécs, Hungary, 7632